Eligibility of Alzheimer's disease clinic patients for clinical trials

Journal of the American Geriatrics Society

Volumn 45, Issue 8, 1997, Pages 923-928

  Schneider, Lon S ^a,b   Olin, Jason T ^a   Lyness, Scott A ^a   Chui, Helena C ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; AGED; ALZHEIMER DISEASE; ARTICLE; BEHAVIOR DISORDER; CLINICAL TRIAL; EDUCATION; FEMALE; GENDER; HUMAN; INCOME; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION;

EID: 0030793014     PISSN: 00028614     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1532-5415.1997.tb02960.x     Document Type: Article

References (19)

1. Chui HC, Lyness S, Sobel E, Schneider LS. Extrapyramidal signs and psychiatric symptoms predict faster rate of progression in Alzheimer's disease. Arch Neurol 1994;51:676-681.
2. Forette F, Bert P, Breuil V, Boller F. Therapeutic drug trials and heterogeneity of Alzheimer's disease. In: Boller F, Forette F, Khachaturian Z, Poncet M, Christian Y, eds. Clinical Heterogeneity in Alzheimer's Disease. New York: Springer-Verlag, 1992, pp 67-73.
3. Khachaturian ZS. An overview of scientific issues associated with the heterogeneity of Alzheimer's disease. In: Boller F, Forette F, Khachaturian Z, Poncet M, Christian Y, eds. Clinical Heterogeneity in Alzheimer's Disease. New York: Springer-Verlag, 1992, pp 1-3.
4. McKhann G, Drachman D, Folstein M et al. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-944.
5. Folstein MF, Folstein SE, McHugh PR. Mini-Mental State: A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
6. Knapp MJ, Knopman DS, Solomon PR et al for the Tacrine Study Group. Controlled trials of high-dose tacrine in patients with Alzheimer's disease. JAMA 1994;271:985-991.
7. Knopman D, Gracon S. Observations on the short-term 'natural history' of probable Alzheimer's disease in a controlled trial. Neurology 1994;44:260-265.
8. Corey-Bloom J, Galasko D, Hofstetter CR et al. Clinical features distinguishing large cohorts with possible AD, probable AD, and mixed dementia. J Am Geriatr Soc 1993;41:31-37.
9. Katzman R, Brown T, Fuld P. Validation of a short Orientation-Memory-Concentration Test of cognitive impairment. Am J Psychiatry 1983;140:734-739.
10. Wragg R, Jeste D. Overview of depression and psychosis in Alzheimer's disease. Am J Psychiatry 1989;46:577-587.
11. Katzman R, Jackson JE. Alzheimer disease: Basic and clinical advances. J Am Geriatr Soc 1991;39:516-525.
12. Mayeux R, Stern Y, Sano M. A comparison of clinical outcome and survival in various forms of Alzheimer's disease. In: Boller F, Forette F, Khachaturian Z, Poncet M, Christian Y, eds. Clinical Heterogeneity in Alzheimer's Disease. New York: Springer-Verlag, 1992, pp 4-11.
13. Drevets WC, Rubins EH. Psychotic symptoms and the longitudinal course of senile dementia of Alzheimer type. Biol Psychiatry 1989;25:39-48.
14. Olin JT, Pawluczyk S, Kaufman GT et al. A comparative analysis of Spanish- and English-speaking Alzheimer's disease patients: Eligibility and interest in clinical drug trials. J Clin Geropsychol 1997;3:183-190.
15. Schneider LS, Pollock VE, Lyness SA. A metaanalysis of controlled trials of neuroleptic treatment of dementia. J Am Geriatr Soc 1990;38:553-563.
16. Thal L, Galasko D, Katzman R et al. Patients clinically assessed at an Alzheimer's Center generally have Alzheimer's pathology. Neurology 1991;41(suppl. 1):323.
17. Farlow MR, Brashear A, Hui S et al. for the Tacrine Study Group. The effects of tacrine in patients with mild versus moderate stage Alzheimer's disease. Neurobiol Aging 1995;15(suppl):S81.
18. Wilcock GK, Ashworth DL, Longfield JA, Smith PM. Detecting patients with Alzheimer's disease suitable for drug treatment: Comparison of three methods of assessment. Br J Gen Pract 1994;44:30-33.
19. Levy MI, Mohs RC, Rosen WG, Davis K. Research subject recruitment for gerontological studies of pharmacological agents. Neurobiol Aging 1982;3:77-79.